180 related articles for article (PubMed ID: 25434799)
1. miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.
Liu P; Tang H; Chen B; He Z; Deng M; Wu M; Liu X; Yang L; Ye F; Xie X
Cancer Lett; 2015 Feb; 357(1):384-392. PubMed ID: 25434799
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
3. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.
Zhang B; Liu XX; He JR; Zhou CX; Guo M; He M; Li MF; Chen GQ; Zhao Q
Carcinogenesis; 2011 Jan; 32(1):2-9. PubMed ID: 20952513
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B
Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
Zhang N; Wang X; Huo Q; Sun M; Cai C; Liu Z; Hu G; Yang Q
Oncogene; 2014 Jun; 33(24):3119-28. PubMed ID: 23851509
[TBL] [Abstract][Full Text] [Related]
6. LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability.
Li PP; Li RG; Huang YQ; Lu JP; Zhang WJ; Wang ZY
Aging (Albany NY); 2021 Nov; 13(21):24171-24191. PubMed ID: 34740994
[TBL] [Abstract][Full Text] [Related]
7. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
[TBL] [Abstract][Full Text] [Related]
9. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
10. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
[TBL] [Abstract][Full Text] [Related]
11. MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.
Chen Z; Ma Y; Pan Y; Zhu H; Yu C; Sun C
Mol Cell Probes; 2018 Aug; 40():19-26. PubMed ID: 29908229
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.
Yu J; Wang JG; Zhang L; Yang HP; Wang L; Ding D; Chen Q; Yang WL; Ren KH; Zhou DM; Zou Q; Jin YT; Liu XP
Oncotarget; 2016 Jun; 7(25):38612-38625. PubMed ID: 27229534
[TBL] [Abstract][Full Text] [Related]
13. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
14. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
[TBL] [Abstract][Full Text] [Related]
16. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
[TBL] [Abstract][Full Text] [Related]
17. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y
Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653
[TBL] [Abstract][Full Text] [Related]
18. microRNA-22 acts as a metastasis suppressor by targeting metadherin in gastric cancer.
Tang Y; Liu X; Su B; Zhang Z; Zeng X; Lei Y; Shan J; Wu Y; Tang H; Su Q
Mol Med Rep; 2015 Jan; 11(1):454-60. PubMed ID: 25323629
[TBL] [Abstract][Full Text] [Related]
19. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.
He R; Liu P; Xie X; Zhou Y; Liao Q; Xiong W; Li X; Li G; Zeng Z; Tang H
J Exp Clin Cancer Res; 2017 Oct; 36(1):145. PubMed ID: 29037220
[TBL] [Abstract][Full Text] [Related]
20. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer.
Yan M; Li X; Tong D; Han C; Zhao R; He Y; Jin X
Oncol Rep; 2016 Jul; 36(1):65-71. PubMed ID: 27108696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]